If you have Medicare Advantage or Medicare Part D, you should not have to pay any out-of-pocket costs for the Shingrix vaccine. To find out exactly how much you will pay, review your plan’s ...

Under the National Vaccination Program, Shingrix is free for people aged 65 and over, Indigenous Australians aged 50 and over, and immunocompromised people aged 18 years and over with certain ...

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Shingrix was also associated with lower ... over are routinely immunised against shingles, while in the UK, a free shingles vaccine is available to people who turn 65, those aged between 70 ...

Shingrix (recombinant varicella-zoster virus) is a brand-name vaccine used to help prevent herpes zoster (shingles) infection in certain adults. Shingrix is not known to interact with other ...

While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme.

Curevo joins other companies hoping to grab market share from Shingrix, which was dubbed the "crown jewel" of GSK's vaccine franchise at the company's latest R&D update and made $2.3 billion in ...

Fellin supports the guidance from the Centers for Disease Control and Prevention and recommends the Shingrix vaccine. It’s given in two doses, with the second given two to six months after the ...

Shingrix is a non-live, recombinant subunit vaccine indicated to prevent shingles in adults 50 and over. It combines an antigen, glycoprotein E, with an adjuvant system, AS01B, and may help ...